Basic Information
Basic information for SNHG14-317-36aa
Peptide Name SNHG14-317-36aa
Genome Position chr15:25234190-25234203,25234575-25234619,25236409-25236453,25239650-25239653[+]
Species Human
Peptide Sequence MTISSELFQTGGLPSIDRQSELCHPGHPPGIDWHRC
Peptide Length 36
Unique No (SNHG14-203-36aa,SNHG14-226-36aa,SNHG14-228-36aa,SNHG14-229-36aa,SNHG14-267-36aa,SNHG14-273-36aa,SNHG14-285-36aa,SNHG14-292-36aa,SNHG14-295-36aa,SNHG14-326-36aa,SNHG14-327-36aa)
Grand Average of Hydropathicity -0.5139
Relative Molecular Mass 4634.08
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000668570;SNHG14-317
Transcript Length 4660
Coding Ability 0.4803
DNA Sequence Corresponding to Peptide ATGACCATATCCAGTGAGCTCTTCCAAACAGGTGGGCTCCCTAGCATTGACCGACAGAGTGAGCTCTGCCACCCAGGACATCCCCCTGGCATTGACTGGCATAGATGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :